Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -141.45% is 38% above its 5-year average of -227.63%, near the high end of its 5-year range (-394.60%–-108.24%).
5.28% above its 12-month average of -149.34%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -152.99%.
OPERATING MARGIN
-141.45%
OPERATING MARGIN AVG TTM
-149.34%
OPERATING MARGIN AVG 3Y
-172.94%
OPERATING MARGIN AVG 5Y
-227.63%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+5.28%
CURRENT VS 3Y AVG
+18.21%
CURRENT VS 5Y AVG
+37.86%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 862 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Rapid Micro Biosystems, Inc.
Market Cap
$42.72M
Operating Margin
-141.45%
TTM Avg
-149.34%
3Y Avg
-172.94%
5Y Avg
-227.63%
Market Cap
$42.83M
Operating Margin
-466.16%
TTM Avg
-484.55%
3Y Avg
-719.99%
5Y Avg
-1266.78%
Market Cap
$42.99M
Operating Margin
-90.49%
TTM Avg
-103.23%
3Y Avg
-126.36%
5Y Avg
-149.14%
Market Cap
$42.26M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$41.95M
Operating Margin
-1.45%
TTM Avg
4.45%
3Y Avg
-26.46%
5Y Avg
-35.98%
Market Cap
$41.83M
Operating Margin
-5.63%
TTM Avg
-15.71%
3Y Avg
-54.38%
5Y Avg
-79.38%
Market Cap
$44.02M
Operating Margin
-163.94%
TTM Avg
-188.75%
3Y Avg
-214.75%
5Y Avg
-271.10%
Market Cap
$44.71M
Operating Margin
11.23%
TTM Avg
13.92%
3Y Avg
-7.07%
5Y Avg
-126.36%
Market Cap
$44.72M
Operating Margin
0.00%
TTM Avg
-1952.10%
3Y Avg
-1112.27%
5Y Avg
-741.51%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Rapid Micro Biosystems, Inc. (RPID) | $42.72M | -141.45% | -149.34% | -172.94% | -227.63% |
| Nano-X Imaging Ltd. (NNOX)vs › | $42.83M | -466.16% | -484.55% | -719.99% | -1266.78% |
| CVRx, Inc. (CVRX)vs › | $42.99M | -90.49% | -103.23% | -126.36% | -149.14% |
| Filana Therapeutics, Inc. (FLNA)vs › | $42.26M | 0.00% | 0.00% | 0.00% | 0.00% |
| BioStem Technologies, Inc. (BSEM)vs › | $41.95M | -1.45% | 4.45% | -26.46% | -35.98% |
| Precipio, Inc. (PRPO)vs › | $41.83M | -5.63% | -15.71% | -54.38% | -79.38% |
| DarioHealth Corp. (DRIO)vs › | $44.02M | -163.94% | -188.75% | -214.75% | -271.10% |
| SANUWAVE Health Inc. (SNWV)vs › | $44.71M | 11.23% | 13.92% | -7.07% | -126.36% |
| Werewolf Therapeutics, Inc. (HOWL)vs › | $44.72M | 0.00% | -1952.10% | -1112.27% | -741.51% |
| Celularity Inc. (CELU)vs › | $45.73M | -230.92% | -150.83% | -322.13% | -477.29% |
Gross Margin
22.6%
Operating Margin
-141.4%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -152.99% |
| 2026-03-31 | -173.11% |
| 2025-12-31 | -108.24% |
| 2025-09-30 | -145.09% |
| 2025-06-30 | -167.28% |
| 2025-03-31 | -161.85% |
| 2024-12-31 | -124.47% |
| 2024-09-30 | -158.32% |
| 2024-06-30 | -202.15% |
| 2024-03-31 | -254.38% |
| 2023-12-31 | -192.33% |
| 2023-09-30 | -235.13% |
| 2023-06-30 | -300.96% |
| 2023-03-31 | -295.37% |
| 2022-12-31 | -394.60% |
| 2022-09-30 | -356.32% |
| 2022-06-30 | -364.61% |
| 2022-03-31 | -360.55% |
| 2021-12-31 | -279.49% |
| 2021-09-30 | -175.72% |
| 2021-06-30 | -177.19% |
| 2021-03-31 | -194.01% |
| 2020-12-31 | -185.47% |
| 2020-09-30 | -144.41% |
| 2020-06-30 | -231.85% |
| 2020-03-31 | -241.28% |
